SCHEMBL24763422

SCHEMBL24763422

CCN=S(=O)(c1ccc(S(=O)(=O)Cl)cc1)N1CCN(C(=O)C(F)(F)F)CC1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.37
▸ PKM P14618 3/20 0.36
▸ YAP1 P46937 3/20 0.35
▸ TEAD4 Q15561 3/20 0.35
▸ TEAD2 Q15562 1/20 0.35
▸ KMT2A Q03164 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ ESR1 P03372 1/20 0.34
▸ ESR2 Q92731 1/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27238558 0.88 GPR183 (0.39) PKMALDH1A1LMNA
SCHEMBL27238539 0.80 PKM (0.40) PKMKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL24762005 0.79 POLB (0.49) POLBPKMKMT2AMEN1CNR1
SCHEMBL24762713 0.79 CNR2 (0.37) KMT2AALDH1A1CNR1
SCHEMBL24762658 0.75 HDAC1 (0.36) POLBPKMKMT2AMEN1ALDH1A1
SCHEMBL1576369 0.74 MAPK1 (0.49) KMT2AMEN1SMN1; SMN2LMNAGAA
SCHEMBL29764391 0.70 LMNA (0.50) PKMKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL24762195 0.70 LMNA (0.50) PKMKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL24762906 0.70 ALDH1A1 (0.53) POLBPKMKMT2AMEN1ALDH1A1
SCHEMBL27238559 0.70 TGM2 (0.46) KMT2AMEN1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240190821-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF TRIANA BIOMEDICINES INC (US) 2024-06-13 — — US disclosed
WO-2022169755-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL) BENZENESULFONAMIDES AND USES THEREOF TRIANA BIOMEDICINES, INC. (US) 2022-08-11 — — WO disclosed
WO-2022169755-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL) BENZENESULFONAMIDES AND USES THEREOF TRIANA BIOMEDICINES, INC. (US) 2022-08-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240190821-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF PACSIN2, TPX2, PRSS12 POLB 4145/4885PKM 4012/4885YAP1 2549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback